Literature DB >> 15578252

[Cooperation between physician and pharmacist to determine and resolve errors in concomitant medication previously prescribed for trauma patients. Quality assurance study].

C Rapke1, G Hofmann, H-W Stedtfeld, G Scherbel.   

Abstract

The problems to be resolved were to develop identification schemes for erroneous long-term medication of newly admitted trauma patients, to detect the nature of medication errors and their frequency of occurrence, to demonstrate the effects by therapy corrections, and to ensure the continuation of optimized prescription after discharge. Upon admission of new trauma surgery patients their current prescriptions are compiled and converted to formulary if possible as well as looked over for medication errors. This procedure is accompanied by an evaluation of the latter.In consequence, the surgeon is able to concentrate on optimizing the current medication to prevent subsequent errors and serious complications.To improve the acceptance of the corrected prescription, patients are advised on their discharge by the pharmacist also. The general practitioners of the patients are informed by an additional pharmacy report concerning sustained medication.A correction of medication errors was necessary in 6.17% of the controlled long-term prescriptions and 20.22% of the controlled 4944 patients. The most common problems were dosage errors; the most serious errors were neglected interactions and side effects. By better cooperation of surgeon and pharmacist we can improve the quality of pharmacotherapy of our patients. The correction of long-term prescriptions provides support and better information to the surgeon. Direct and indirect expenses can be reduced.

Entities:  

Mesh:

Year:  2004        PMID: 15578252     DOI: 10.1007/s00113-004-0826-7

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  8 in total

1.  Suspected adverse drug events requiring emergency department visits or hospital admissions.

Authors:  R Raschetti; M Morgutti; F Menniti-Ippolito; A Belisari; A Rossignoli; P Longhini; C La Guidara
Journal:  Eur J Clin Pharmacol       Date:  1999-02       Impact factor: 2.953

2.  Exploring the causes of adverse events in NHS hospital practice.

Authors:  G Neale; M Woloshynowych; C Vincent
Journal:  J R Soc Med       Date:  2001-07       Impact factor: 5.344

3.  Harvey A. K. Whitney Lecture. Initiatives for reducing medication errors: the time is now.

Authors:  N M Davis
Journal:  Am J Health Syst Pharm       Date:  2000-08-15       Impact factor: 2.637

4.  Drug related admissions to medical wards: a population based survey.

Authors:  J Hallas; L F Gram; E Grodum; N Damsbo; K Brøsen; T Haghfelt; B Harvald; J Beck-Nielsen; J Worm; K B Jensen
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

5.  Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  1998-01-15       Impact factor: 2.637

6.  Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.

Authors:  R Lagnaoui; N Moore; J Fach; M Longy-Boursier; B Bégaud
Journal:  Eur J Clin Pharmacol       Date:  2000-05       Impact factor: 2.953

7.  ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  1995-02-15       Impact factor: 2.637

Review 8.  ASHP guidelines on preventing medication errors in hospitals.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1993-02
  8 in total
  2 in total

Review 1.  [Is there an improvement of drug safety in Germany in recent years?].

Authors:  M Völkel; A Bussmann-Rolfes; J C Frölich
Journal:  Internist (Berl)       Date:  2009-11       Impact factor: 0.743

2.  Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany.

Authors:  L Cortejoso; R A Dietz; G Hofmann; M Gosch; A Sattler
Journal:  Clin Interv Aging       Date:  2016-09-26       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.